PAYX vs VRSN Stock Comparison
Paychex, Inc. vs VeriSign, Inc.
PAYX leads
PAYX leads by 6 AIQ points, primarily on Quality and Risk Resilience, but the lead has narrowed from 15 points over 30 sessions. Wall Street currently favors VRSN on target upside.
Fragile: 4 of 6 evidence groups support PAYX, its lead is narrowing, and its current signal state is conflicted.
Paychex, Inc.
VeriSign, Inc.
The Algovestiq AIQ Score currently favors PAYX over VRSN, 63 versus 57 as of Sep 5, 2026. PAYX's advantage is driven primarily by stronger quality and risk resilience, while VRSN holds the stronger momentum profile. PAYX also shows the weaker technical structure relative to its 50-day moving average, though analyst target upside currently favors VRSN. 4 of 6 covered evidence groups favor PAYX today, and the comparison is rated Fragile on stability: the leader's advantage has been narrowing. PAYX lead: Weakening — the AIQ differential moved from 15 to 6 points over 30 sessions.
Compare Paychex, Inc. and VeriSign, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Compare PAYX and VRSN against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Quality30%81 vs 60PAYX +21
- Momentum25%66 vs 79VRSN +13
- Risk Resilience15%59 vs 47PAYX +12
- Value30%45 vs 40PAYX +5
4 of 6 evidence groups favor PAYX. PAYX’s edge is concentrated in quality and risk resilience; VRSN keeps a meaningful momentum edge.
What changed since the last close
Latest scored session 2026-09-04, compared against the prior scored session 2026-09-03.
Largest factor move: Momentum -1
No new signals fired.
Largest factor move: Momentum +10
New signals
- RSI Overbought — bearish, momentum, short horizon
PAYX's lead narrowed by 4 AIQ points in the latest snapshot.
Deeper signal detail for each name lives on its own signals page — PAYX and VRSN both carry a full feed there.
The central trade-off
PAYX (Paychex, Inc.): the stronger current systematic profile, led by quality and risk resilience.
VRSN (VeriSign, Inc.): the counter-case, on momentum, fundamentals, analyst expectations.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
PAYXPAYX on the overall AIQ Score, which weights Quality and Value at 30% each.
Growth
VRSNVRSN on combined revenue and EPS growth.
Value
PAYXPAYX on the peer-relative Value factor, by 5 points.
Momentum
VRSNVRSN on the Momentum factor, by 13 points.
Lower downside
PAYXPAYX on Risk Resilience, by 12 points.
Analyst upside
VRSNVRSN on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors PAYX, analyst targets favor VRSN. That disagreement is the most useful thing on this page.
| Measure | PAYX | VRSN | Note |
|---|---|---|---|
| Implied upside to target | -12.1% | +16.2% | VRSN has more room |
| Target dispersion | +15.9% | +9.1% | Lower is tighter analyst agreement |
| Consensus | Hold | Hold | Context, not a primary driver |
| Analysts covering | 5 | 2 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
4 of 6 covered evidence groups favor PAYX. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | PAYX | 63 vs 57 |
| Fundamentals | VRSNon balance | revenue growth -11.2% vs 1.3%; EPS growth -24.4% vs 1.7%; TTM ROE 45.1% vs -39.2%; gross margin 74.3% vs 88.5%; operating margin 38.6% vs 67.9% — VRSN takes 4 of 5 decided legs, not all of them |
| Valuation | PAYX | Value 45 vs 40 |
| Technicals | PAYX | Price vs 50-day 4.6% vs 4.7%; vs 200-day 17% vs 11.6% |
| Risk Resilience | PAYX | Risk Resilience 59 vs 47 |
| Analyst expectations | VRSN | Target upside -12.1% vs 16.2% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of PAYX and VRSN and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is moderate at 6 points.
- The leader's advantage has been narrowing. (argues the conclusion is provisional)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on PAYX.
How the comparison changed
120 daily snapshots · Apr 23 – Sep 4PAYX lead: Weakening — the AIQ differential moved from 15 to 6 points over 30 sessions.
- Today
- PAYX +6
- 63 vs 57
- 7 sessions ago
- PAYX +13
- 66 vs 53
- 30 sessions ago
- PAYX +15
- 67 vs 52
- 90 sessions ago
- PAYX +20
- 61 vs 41
The lead changed hands once in this window, most recently on May 13 when VRSN moved ahead of PAYX.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
3 bullish / 1 bearish, conflicted
- Golden Cross Active — bullish, trend, long horizon (11.87%)
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- Uptrend Structure Active — bullish, trend, long horizon
4 bullish / 1 bearish, conflicted
- Golden Cross Active — bullish, trend, long horizon (6.60%)
- RSI Overbought — bearish, momentum, short horizon
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
PAYX leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price and the AIQ Score both moved down over the latest session (price -2.69%, AIQ -1 points).
Price is down while the AIQ Score moved up 3 points over the same session — price and model disagree (price -0.43%, AIQ +3 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1VRSN closes the Quality gap — currently 21 points behind, the largest single contributor to PAYX's edge.
- 2VRSN's RSI Overbought resolves — a bearish momentum rule currently active against it.
- 3PAYX's conflicting signal state resolves bearish — it currently carries 3 bullish and 1 bearish rules at once.
- 4The narrowing continues — the lead has already given back 9 points over 30 sessions, and a further 6-point move would eliminate PAYX's advantage entirely.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
VRSN leads on balance| Metric | PAYX | VRSN |
|---|---|---|
| Revenue growth (YoY) | -11.2% | 1.3% |
| EPS growth (YoY) | -24.4% | 1.7% |
| Gross margin | 74.3% | 88.5% |
| Operating margin | 38.6% | 67.9% |
| Return on equity (TTM) | 45.1% | -39.2% |
| Debt to equity | 1.24 | -1.04 |
Performance
Split across windows| Metric | PAYX | VRSN |
|---|---|---|
| 1 week (5 sessions) | -4.2% | 0.1% |
| 1 month (20 sessions) | 1.4% | -0.8% |
| 3 months (63 sessions) | 21.1% | -1% |
| 6 months (126 sessions) | 20.7% | 19.8% |
| Year to date | 8.5% | 20.2% |
| 1 year (252 sessions) | -10.3% | 6.6% |
Technicals
PAYX has the stronger structure| Metric | PAYX | VRSN |
|---|---|---|
| RSI (14) | 58.4 | 72.1 |
| ADX (14) | 30.9 | 17 |
| Price vs 50-day | 4.6% | 4.7% |
| Price vs 200-day | 17% | 11.6% |
| Volatility (1M, annualized) | 27.6% | 26% |
Risk
PAYX is the more resilient| Metric | PAYX | VRSN |
|---|---|---|
| Beta | -0.01 | -0.02 |
| Sharpe ratio | -0.43 | 0.19 |
| Sortino ratio | -0.67 | 0.26 |
| Max drawdown | -37.7% | -26.9% |
| Current drawdown | -11.4% | -5.8% |
| Annualized volatility | 28.1% | 28.8% |
| Value at risk (95%) | -2.8% | -3% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, PAYX or VRSN?
On the Algovestiq AIQ Score, PAYX is the stronger of the two as of Sep 5, 2026, scoring 63 against VRSN's 57. The edge comes from quality and risk resilience. VRSN is not without a case — it holds the better momentum profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is PAYX or VRSN the better buy right now?
PAYX carries the stronger systematic profile as of Sep 5, 2026, and the comparison is rated Fragile — 4 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the leader's advantage has been narrowing. Treat the lead as provisional.
Why does the AIQ Score favor PAYX over VRSN?
The composite weights Quality at 30%, Value at 30%, Momentum at 25% and Risk Resilience at 15%. PAYX leads Quality by 21 points; VRSN leads Momentum by 13 points; PAYX leads Risk Resilience by 12 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, PAYX or VRSN?
Analyst price targets imply -12.1% upside for PAYX and +16.2% for VRSN, so the Street currently favors VRSN. That points the opposite way to the AIQ Score, which favors PAYX. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, PAYX or VRSN?
PAYX is the better-valued of the two on the peer-relative Value factor. PAYX on the peer-relative Value factor, by 5 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, PAYX or VRSN?
VRSN on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, PAYX or VRSN?
VRSN on the Momentum factor, by 13 points. Momentum carries 25% of the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, PAYX or VRSN?
PAYX is the more resilient of the two, so the other name carries the higher downside risk. PAYX on Risk Resilience, by 12 points. The Risk Resilience factor weights 15% of the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is PAYX more profitable than VRSN?
The profitability evidence is mixed: gross margin 74.3% vs 88.5%; operating margin 38.6% vs 67.9%; ttm roe 45.1% vs -39.2%. PAYX leads on one measure and VRSN on two measures, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.
Is PAYX's lead over VRSN getting stronger or weaker?
PAYX lead: Weakening — the AIQ differential moved from 15 to 6 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-04-23 and 2026-09-04. The lead has changed hands once in that window, most recently on 2026-05-13, when VRSN moved ahead of PAYX.
What would change the PAYX vs VRSN verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: VRSN closes the Quality gap — currently 21 points behind, the largest single contributor to PAYX's edge; VRSN's RSI Overbought resolves — a bearish momentum rule currently active against it; PAYX's conflicting signal state resolves bearish — it currently carries 3 bullish and 1 bearish rules at once; the narrowing continues — the lead has already given back 9 points over 30 sessions, and a further 6-point move would eliminate PAYX's advantage entirely.
What do the current signals say about PAYX and VRSN?
PAYX: 3 bullish / 1 bearish, conflicted. VRSN: 4 bullish / 1 bearish, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on PAYX is Golden Cross Active (bullish, long horizon). On VRSN it is Golden Cross Active (bullish, long horizon).
Compare PAYX and VRSN with others
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality (30%), Value (30%), Momentum (25%) and Risk (15%). Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.